Scarica l'app Stockscreener
81.13
22.84%
-23.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$104.84
Aprire:
$89.9
Volume 24 ore:
4.95M
Relative Volume:
5.34
Capitalizzazione di mercato:
$7.13B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
13.50
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-22.47%
1M Prestazione:
-15.25%
6M Prestazione:
-8.40%
1 anno Prestazione:
+6.43%
Intervallo 1D:
$80.00
$89.90
Intervallo di 1 settimana:
$80.00
$108.91
Portata 52W:
$74.28
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
81.08 | 7.13B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
154.78 | 69.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.07 | 48.09B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.81 | 46.34B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.45 | 18.47B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.03 | 13.57B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Lantheus Holdings (LNTH) Stock Drops After Lowering 2025 Outlook - GuruFocus
Lantheus Holdings stock drops on lowered full year outlook - MSN
Lantheus Holdings (LNTH) Revises 2025 Revenue Guidance Amid Strategic Shifts - GuruFocus
Lantheus stock down on guidance cut (LNTH:NASDAQ) - Seeking Alpha
Transcript : Lantheus Holdings, Inc., Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Earnings call transcript: Lantheus Q1 2025 results miss estimates, stock drops - Investing.com
Lantheus Holdings (LNTH) Misses Q1 Earnings and Revenue Estimates - GuruFocus
Lantheus' Q1 Adjusted Earnings Fall, Revenue Rises; Trims 2025 Adjusted Earnings Guidance - marketscreener.com
Lantheus Holdings Inc Reports Q1 2025 Earnings: Adjusted EPS of $1.53 Beats Estimates, Revenue of $372.8 Million Misses Expectations - GuruFocus
Lantheus (LNTH) Reports Q1 Revenue and Strategic Acquisitions | LNTH Stock News - GuruFocus
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Lantheus Holdings: Q1 Earnings Snapshot - The Washington Post
Lantheus Q1 2025 slides: Revenue flat, EPS down as company focuses on acquisitions - Investing.com India
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Lantheus to sell SPECT Business to SHINE Technologies - MSN
Lantheus announces plans to divest SPECT imaging business - Radiology Business
Lantheus Announces Sale of SPECT Business to SHINE Technologies - The Manila Times
Lantheus divests SPECT business to SHINE Technologies - Investing.com
SHINE Technologies Announces Plan to Acquire Lantheus' SPECT Division, Expanding Market Reach and Leadership in Nuclear Medicine - Yahoo Finance
Lantheus Earnings: What To Look For From LNTH - Yahoo Finance
Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results - Yahoo Finance
Lantheus (LNTH) Advances Alzheimer's Imaging Agent MK-6240 - GuruFocus
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - Seeking Alpha
Fund Update: BRIDGES INVESTMENT MANAGEMENT INC added 13,439 shares of LANTHEUS HOLDINGS ($LNTH) to their portfolio - Nasdaq
Lantheus Says Alzheimer's Disease Radiodiagnostic MK-6240 Meets Primary Endpoints in Two Trials - marketscreener.com
Lantheus (LNTH) Achieves Key Milestones with MK-6240 Radiodiagno - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool By Investing.com - Investing.com India
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 M - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool - Investing.com Australia
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies - The Manila Times
Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool - Nasdaq
Lantheus Announces Alzheimer's Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies - marketscreener.com
Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next - Stock Titan
Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now - MSN
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer Imaging Agent - PCF | Prostate Cancer Foundation
Lantheus Holdings Inc (LNTH) Shares Gap Down to $100.08 on Apr 2 - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
11 Stocks with Consistent Growth to Buy Now - Insider Monkey
Lantheus to Host First Quarter 2025 Earnings Conference Call and - GuruFocus
Lantheus Holdings, Inc. Announces Conference Call to Discuss Q1 2025 Financial Results - Nasdaq
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Q1 2025 Earnings Call: How to Join the May 7 Investor Presentation - Stock Titan
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Could Be 44% Below Their Intrinsic Value Estimate - simplywall.st
In tough environment, Lantheus has cash and plans to use it - The Business Journals
(LNTH) Proactive Strategies - news.stocktradersdaily.com
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - The Globe and Mail
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights - Investing.com India
Stocks With Rising Composite Ratings: Lantheus Holdings - Investor's Business Daily
LNTH Quantitative Stock Analysis - Nasdaq
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
20.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):